2020-06-28
W World Corp., a biopharmaceutical company, announces its intention to get listed on NASDAQ on 2020/2021, opening speech by Professor Dr. OUDOM, Chairman of the W World Corp, June 28, 2020 at 0:00 a.m., New York.
W World Corp. is a globally focused biopharmaceutical company dedicated to build the global health industry chain and become a leader in the development of innovative and impactful drugs for the treatment of diseases, especially cancer diseases.
W World Corp. invests in biopharmaceutical health industry in Asia, Oceania, Australia, and Vanuatu, including the third-largest region in Europe. The company has established a long-term strategic partnership with hospitals around the world with high reputation, and started the cooperation of building 33 rehabilitation centers, striving for a new road in the field of medical treatment of cancer and other special diseases.
W World Corp. has maintained a strategic partnership with five universities in Thailand, including Royal University of South Tower, National Xi Ba Gong University, National Northeast University of Science and Technology, National Meizhou University and the National University of Technology, striving for an international breakthrough in the field of medical research, processing and extraction.
In line with the enterprise philosophy of "Serving human health all over the world", W World Corp. will be committed to building a whole health industrial chain integrating the fields of medical treatment, pharmaceutical industry, health education, and training.
멜론 파이낸셜 그룹의 아시아 태평양 지역 본부가 한국으로 이전하면 한국 투자자들에게 어떤 영향을 끼칠가요
中 쯔허 바이오 (Zhihe Bio) 인코스메틱 글로벌 전시회(In-Cosmetics Global 2024) 참가
중국츠핑: 산업폐기물의새로운용도
중국츠핑: 2만명의실용인재가농촌진흥을돕다
T314 프로토콜은 ERC314 기술을 바이낸스 스마트 체인에 적용합니다.
중국요성경제개발구: 디지털화정무서비스혁신전개